These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 14962580)

  • 61. Regulation and evaluation of diagnostic products.
    Eavenson E
    Med Instrum; 1974; 8(1):59-62. PubMed ID: 4812344
    [No Abstract]   [Full Text] [Related]  

  • 62. Promoting, improving and accelerating the drug development and approval processes.
    Graul AI
    Drug News Perspect; 2007; 20(1):45-55. PubMed ID: 17332899
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Modeling and prediction of cocrystal phase diagrams.
    Ainouz A; Authelin JR; Billot P; Lieberman H
    Int J Pharm; 2009 Jun; 374(1-2):82-9. PubMed ID: 19446763
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Current status of international drug regulation.
    Lasagna L
    Med Mark Media; 1978 Feb; 13(2):37-8, 40, 42-5. PubMed ID: 10316569
    [No Abstract]   [Full Text] [Related]  

  • 65. Accelerated approvals under the microscope.
    Mullard A
    Nat Rev Drug Discov; 2021 Jun; 20(6):409-411. PubMed ID: 34012001
    [No Abstract]   [Full Text] [Related]  

  • 66. Turning a blind eye.
    Nat Med; 2008 Jan; 14(1):1. PubMed ID: 18180702
    [No Abstract]   [Full Text] [Related]  

  • 67. Solubility of molecular crystals: polymorphism in the light of solubility theory.
    Bennema P; van Eupen J; van der Wolf BM; Los JH; Meekes H
    Int J Pharm; 2008 Mar; 351(1-2):74-91. PubMed ID: 17980982
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Strong medicine.
    Wadman M
    Nat Med; 2005 May; 11(5):465-6. PubMed ID: 15875044
    [No Abstract]   [Full Text] [Related]  

  • 69. Official USP Reference Standards: metrology concepts, overview, and scientific issues and opportunities.
    Williams RL; ;
    J Pharm Biomed Anal; 2006 Jan; 40(1):3-15. PubMed ID: 16303277
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A material science perspective of pharmaceutical solids.
    Cui Y
    Int J Pharm; 2007 Jul; 339(1-2):3-18. PubMed ID: 17537600
    [TBL] [Abstract][Full Text] [Related]  

  • 71. FDA attempting to overcome major roadblocks in monitoring drug safety.
    Zielinski SL
    J Natl Cancer Inst; 2005 Jun; 97(12):872-3. PubMed ID: 15956645
    [No Abstract]   [Full Text] [Related]  

  • 72. Regulatory watch: Efficiency indicators for new drugs approved by the FDA from 2003 to 2013.
    Belleli R; Fisch R; Szucs TD
    Nat Rev Drug Discov; 2015 Mar; 14(3):156. PubMed ID: 25722232
    [No Abstract]   [Full Text] [Related]  

  • 73. The computational prediction of pharmaceutical crystal structures and polymorphism.
    Price SL
    Adv Drug Deliv Rev; 2004 Feb; 56(3):301-19. PubMed ID: 14962583
    [TBL] [Abstract][Full Text] [Related]  

  • 74. "Insuring" the continued solvency of pharmaceutical companies in the face of product liability class actions.
    Chodock R; Yolkut D; Connolly DR
    Tort Trial Insur Pract Law J; 2005; 40(3):997-1017. PubMed ID: 16100814
    [TBL] [Abstract][Full Text] [Related]  

  • 75. New drugs of 1996.
    Hussar DA
    J Am Pharm Assoc (Wash); 1997; NS37(2):192-228; quiz 228-32. PubMed ID: 9069693
    [No Abstract]   [Full Text] [Related]  

  • 76. [Quality control, current need of laboratories of clinical chemistry].
    Grisler R
    Recenti Prog Med; 1967 Jan; 42(1):33-56. PubMed ID: 5632707
    [No Abstract]   [Full Text] [Related]  

  • 77. Researching new drugs.
    Iowa Med; 1988 May; 78(5):230-3. PubMed ID: 3391751
    [No Abstract]   [Full Text] [Related]  

  • 78. International Conference on Harmonisation; guidance on Q8(R1) Pharmaceutical Development; addition of annex; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Jun; 74(109):27325-6. PubMed ID: 19588572
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [The use of the differential scanning method in drug analysis].
    Károly N; Sándor G; Janisz S; Károlyné N
    Acta Pharm Hung; 1976 Nov; 46(5-6):205-12. PubMed ID: 1020644
    [No Abstract]   [Full Text] [Related]  

  • 80. Supramolecular medicinal chemistry: mixed-ligand coordination complexes.
    Ma Z; Moulton B
    Mol Pharm; 2007; 4(3):373-85. PubMed ID: 17497887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.